Compare · BIOS vs CVII
BIOS vs CVII
Side-by-side comparison of BioPlus Acquisition Corp. (BIOS) and Churchill Capital Corp VII (CVII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOS and CVII operate in Blank Checks (Finance), so they compete in similar markets.
- CVII carries a market cap of $1.68B.
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Churchill Capital Corp VII
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Latest BIOS
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by BioPlus Acquisition Corp.
- SEC Form 25-NSE filed by BioPlus Acquisition Corp.
- SEC Form RW filed by BioPlus Acquisition Corp.
- Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
- BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest CVII
- Amendment: SEC Form SC 13G/A filed by Churchill Capital Corp VII
- SEC Form 15-12G filed by Churchill Capital Corp VII
- Large owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)
- Churchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Churchill Capital Corp VII
- Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination
- SEC Form 10-Q filed by Churchill Capital Corp VII
- Churchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Churchill Capital Corp VII
- SEC Form DEFA14A filed by Churchill Capital Corp VII